Archive for October, 2013

Congratulations to Christian Heinis – 2013 MedChemComm Lectureship winner

Christian HeinisCongratulations to Professor Christian Heinis from École Polytechnique Fédérale de Lausanne, Switzerland, who is the recipient of the 2013 MedChemComm Emerging Investigator Lectureship.

Professor Heinis receives the Lectureship in recognition of his research into drugs in the “middle space” between small molecules and biologicals, in particular for his work on cyclic peptide therapeutics.He will deliver the lecture at the 2014 EFMC International Symposium on Medicinal Chemistry in Lisbon, Portugal.

The  annual MedChemComm Emerging Investigator Lectureship is given to a researcher who has made a significant contribution to medicinal chemistry research in the early part of their career. The recipient must also have published an article in MedChemComm. Nominations are received from members of the public and the recipient is chosen by a committee formed of members of the Editorial Board.        


Biography of Christian Heinis

Christian Heinis studied biochemistry at the Swiss Federal Institute of Technology in Zurich (ETHZ) where he also did a PhD in the research group of Prof. Dr. Dario Neri. He was a postdoctoral fellow in the group of Prof. Dr. Kai Johnsson at the Ecole Polytechnique Fédéral de Lausanne (EPFL) and in the group of Sir Gregory Winter at the Laboratory of Molecular Biology (LMB) in Cambridge, UK. In 2008 he was appointed Assistant Professor with tenure track for Bioorganic Chemistry at EPFL and since 2009 he is holding a professorship of the Swiss National Science Foundation. The general research interest of Christian Heinis is the development of novel and innovative therapeutic strategies using chemical and biological methodologies and tools. Christian is a scientific founder of the start-up company Bicycle Therapeutics.


Recent articles in MedChemComm by Christian Heinis

Phage display libraries of differently sized bicyclic peptides
Inmaculada Rentero Rebollo, Alessandro Angelini and Christian Heinis  
Med. Chem. Commun., 2013,4, 145-150

 Graphical Abstract

Strategies to prolong the plasma residence time of peptide drugs
Lisa Pollaro and Christian Heinis  
Med. Chem. Commun., 2010,1, 319-324

Graphical Abstract

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

4th CPA-RSC Symposium on Medicinal Chemistry: Epigenetics as Targets for Drug Discovery

The RSC is jointly hosting a Medicinal Chemistry symposia on epigenetics as targets for drug discovery, comprising of two events:

4th CPA-RSC Symposium on Medicinal Chemistry: Epigenetics as Targets for Drug Discovery
Shandong University, Jinan, 2-3 November 2013

RSC International symposium on Epigenetics
Shanghai Institute of Materia Medica, 5 November 2013

The symposia will focus on epigenetics as targets for drug discovery, including trends and frontiers in epigenetics and histone modulators. It will feature a mix of high-profile international speakers and Chinese speakers from both academia and industry.

4th CPA-RSC Symposium on Medicinal Chemistry: Epigenetics as Targets for Drug Discovery:

The 2013 Chinese Medicinal Chemistry Symposium (CMCS) and the 4th CPA-RSC Symposium on Medicinal Chemistry: Epigenetics as Targets for Drug Discovery will be held from November 2 to 3, 2013 in Jinan, China. It is co-sponsored by Medicinal Chemistry Professional Committee of Chinese Pharmaceutical Association and Royal Society of Chemistry, and organized by Shandong University.

The symposium aims to provide a platform for medicinal chemists to exchange research information, discuss challenges, promote collaboration, and facilitate the transfer of new technologies. This symposium will showcase cutting-edge and complementary medicinal chemistry approaches ranging from complex natural products to small molecule fragments

Speakers include:

  • Chun-Wa Chung, GlaxoSmithKline, Stevenage, UK
  • Paul BrennanSGC Oxford, UK
  • Qi JunHarvard Medical School, USA
  • Paul Thompson, Scripps Research Institute, Florida, USA
  • Erik De Clerq, Katholieke Universiteit Leuven, Belgium
  • Luo ChengShanghai Institute of Materia Medica, China
  • Lu Xianping, Chipscreen Biosciences Ltd, China
  • Y. George Zheng, University of Georgia, USA
  • Zhang Mingqiang, Regional Associate Editor MedChemComm and VP Amgen, Shanghai, China
  • Hao Fang, Shandong University, China
  • David James, Royal Society of Chemistry, UK

RSC International symposium on Epigenetics:

This event will be hosted by Professor Jingkang Shen. If you are interested in attending this event, please email Dr Qingqing Qi with your contact details and email address.

Speakers include:

  • Chun-Wa ChungGlaxoSmithKline, Stevenage, UK
  • Paul BrennanSGC Oxford, UK
  • Qi JunHarvard Medical School, USA
Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)